← Leaderboards
Thomas Tuschl
Rockefeller University
$29,870,416
Attributed
$38,778,617
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$52,108,848 · 20
By mechanism
U19$19,851,966 · 6
R01$12,679,771 · 5
P01$8,885,546 · 3
UH2$7,337,248 · 2
UH3$2,509,396 · 1
RC1$831,921 · 1
Top collaborators
- Jill P Buyon11 shared
- Chaim Putterman11 shared
- Uwe Ohler5 shared
- Dinshaw J Patel5 shared
- Manikkam Suthanthiran5 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsStructureBaseRibonucleoproteinsTissuesSamplingFutureSystemic Lupus ErythematosusAffectRegulationMicrornasInsightSerumMessenger RnaLeadResearch PersonnelGenesGene ExpressionProteinsTechnologyBiochemicalCollaborationsProtocols DocumentationCell Type
Grant awards (83)
Discovery of new antiviral methylase, protease, and helicase inhibitors of corona-, flavi-, and alphaviruses$5,701,101
U19 · FY2022 · AI · contact PI
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expression$497,864
R01 · FY2022 · AI · contact PI
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expression$505,592
R01 · FY2021 · AI · contact PI
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expression$513,131
R01 · FY2020 · AI · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$481,619
UH2 · FY2020 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$1,117,810
UH2 · FY2019 · AR
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expression$538,003
R01 · FY2019 · AI · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$105,524
UH2 · FY2019 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$944,516
UH2 · FY2018 · AR
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function$1,343,908
U19 · FY2017 · CA · contact PI
Clinical utility of extracellular RNA as marker of kidney disease progression$835,118
UH3 · FY2017 · TR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$686,349
UH2 · FY2017 · AR
ExRNA composition in SLE patients and factors influencing exRNP abundance and th$411,106
U19 · FY2017 · CA · contact PI
Einstein Lupus Cohort Core$378,252
U19 · FY2017 · CA · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$366,395
UH2 · FY2017 · AR
Elucidation of human serum RNA and RNP composition$310,810
U19 · FY2017 · CA · contact PI
Biochemical and structural characterization of RNA turnover processes and resolu$243,740
U19 · FY2017 · CA · contact PI
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function$77,123
U19 · FY2017 · CA · contact PI
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function$1,346,910
U19 · FY2016 · CA · contact PI
Posttranscriptional regulation by mRNA-binding shuttling and transport proteins$876,432
R01 · FY2016 · GM · contact PI
Clinical utility of extracellular RNA as marker of kidney disease progression$835,584
UH3 · FY2016 · TR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$578,905
UH2 · FY2016 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$498,441
UH2 · FY2016 · AR
ExRNA composition in SLE patients and factors influencing exRNP abundance and th$411,438
U19 · FY2016 · CA · contact PI
Einstein Lupus Cohort Core$378,584
U19 · FY2016 · CA · contact PI
Elucidation of human serum RNA and RNP composition$310,715
U19 · FY2016 · CA · contact PI
Biochemical and structural characterization of RNA turnover processes and resolu$246,173
U19 · FY2016 · CA · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$169,500
UH2 · FY2016 · AR
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function$1,408,766
U19 · FY2015 · CA · contact PI
Posttranscriptional regulation by mRNA-binding shuttling and transport proteins$876,432
R01 · FY2015 · GM · contact PI
Clinical utility of extracellular RNA as marker of kidney disease progression$838,694
UH3 · FY2015 · TR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$700,001
UH2 · FY2015 · AR
ExRNA composition in SLE patients and factors influencing exRNP abundance and th$417,385
U19 · FY2015 · CA · contact PI
Einstein Lupus Cohort Core$384,570
U19 · FY2015 · CA · contact PI
Development of quantitative multiplex RNA in situ hybridization$359,328
R01 · FY2015 · CA · contact PI
Elucidation of human serum RNA and RNP composition$352,440
U19 · FY2015 · CA · contact PI
Biochemical and structural characterization of RNA turnover processes and resolu$254,371
U19 · FY2015 · CA · contact PI
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function$1,420,133
U19 · FY2014 · CA · contact PI
Posttranscriptional regulation by mRNA-binding shuttling and transport proteins$876,432
R01 · FY2014 · GM · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$700,001
UH2 · FY2014 · AR
Clinical utility of extracellular RNA as marker of kidney disease progression$488,188
UH2 · FY2014 · TR · contact PI
ExRNA composition in SLE patients and factors influencing exRNP abundance and th$418,843
U19 · FY2014 · CA · contact PI
Einstein Lupus Cohort Core$385,988
U19 · FY2014 · CA · contact PI
Elucidation of human serum RNA and RNP composition$357,646
U19 · FY2014 · CA · contact PI
Development of quantitative multiplex RNA in situ hybridization$345,751
R01 · FY2014 · CA · contact PI
Biochemical and structural characterization of RNA turnover processes and resolu$257,656
U19 · FY2014 · CA · contact PI
Definition of Serum Ribonucleoprotein Composition and its Regulation and Function$1,517,154
U19 · FY2013 · CA · contact PI
Posttranscriptional regulation by mRNA-binding shuttling and transport proteins$850,140
R01 · FY2013 · GM · contact PI
Clinical utility of extracellular RNA as marker of kidney disease progression$499,999
UH2 · FY2013 · TR · contact PI
ExRNA composition in SLE patients and factors influencing exRNP abundance and th$436,414
U19 · FY2013 · CA · contact PI
Einstein Lupus Cohort Core$403,561
U19 · FY2013 · CA · contact PI
Elucidation of human serum RNA and RNP composition$399,358
U19 · FY2013 · CA · contact PI
Development of quantitative multiplex RNA in situ hybridization$335,058
R01 · FY2013 · CA · contact PI
Biochemical and structural characterization of RNA turnover processes and resolu$277,821
U19 · FY2013 · CA · contact PI
Posttranscriptional regulation by mRNA-binding shuttling and transport proteins$910,617
R01 · FY2012 · GM · contact PI
Development of quantitative multiplex RNA in situ hybridization$353,560
R01 · FY2012 · CA · contact PI
miRNA Gene Regulatory Networks and their Role in Diseases of the Nervous System$567,032
R01 · FY2011 · MH · contact PI
Development of quantitative multiplex RNA in situ hybridization$369,859
R01 · FY2011 · CA · contact PI
miRNA Gene Regulatory Networks and their Role in Diseases of the Nervous System$572,759
R01 · FY2010 · MH · contact PI
Developing miRNA diagnostic methods and identifying tumor regulatory networks$421,442
RC1 · FY2010 · CA · contact PI
The function of small RNAs in mammals$1,212,116
P01 · FY2009 · GM · contact PI
Cell type-specific dissection of RNA silencing networks$582,545
P01 · FY2009 · GM · contact PI
miRNA Gene Regulatory Networks and their Role in Diseases of the Nervous System$563,959
R01 · FY2009 · MH · contact PI
Developing miRNA diagnostic methods and identifying tumor regulatory networks$410,479
RC1 · FY2009 · CA · contact PI
miRNA Gene Regulatory Networks and their Role in Diseases of the Nervous System$11,760
R01 · FY2009 · MH · contact PI
The function of small RNAs in mammals$1,200,263
P01 · FY2008 · GM · contact PI
Cell type-specific dissection of RNA silencing networks$572,147
P01 · FY2008 · GM · contact PI
miRNA Gene Regulatory Networks and their Role in Diseases of the Nervous System$545,821
R01 · FY2008 · MH · contact PI
The function of small RNAs in mammals$1,217,772
P01 · FY2007 · GM · contact PI
Cell type-specific dissection of RNA silencing networks$578,088
P01 · FY2007 · GM · contact PI
miRNA Gene Regulatory Networks and their Role in Diseases of the Nervous System$562,746
R01 · FY2007 · MH · contact PI
Biochemical analysis of siRNA/miRNA function in human$284,548
R01 · FY2007 · GM · contact PI
The function of small RNAs in mammals$1,232,894
P01 · FY2006 · GM · contact PI
Cell type-specific dissection of RNA silencing networks$463,148
P01 · FY2006 · GM · contact PI
Biochemical analysis of siRNA/miRNA function in human$293,046
R01 · FY2006 · GM · contact PI
The function of small RNAs in mammals$1,353,192
P01 · FY2005 · GM
Cell type-specific dissection of RNA silencing networks$453,402
P01 · FY2005 · GM
Biochemical analysis of siRNA/miRNA function in human$363,260
R01 · FY2005 · GM
The function of small RNAs in mammals$19,979
P01 · FY2005 · GM
1st Annual Meeting-Oligonucleotide Therapeutics Society$10,000
R13 · FY2005 · CA
Biochemical analysis of siRNA/miRNA function in human$362,275
R01 · FY2004 · GM
siRNAs and miRNAs$3,000
R13 · FY2004 · CA
Biochemical analysis of siRNA/miRNA function in human$344,366
R01 · FY2003 · GM